- Previous close
2,326.00 - Open
2,330.00 - Bid 2,326.00 x --
- Ask 2,329.00 x --
- Day's range
2,321.00 - 2,330.00 - 52-week range
2,278.00 - 2,879.00 - Volume
8,800 - Avg. Volume
38,923 - Market cap (intra-day)
70.676B - Beta (5Y monthly) -0.19
- PE ratio (TTM)
8.82 - EPS (TTM)
264.00 - Earnings date 14 Feb 2025
- Forward dividend & yield 81.00 (3.07%)
- Ex-dividend date 28 Mar 2025
- 1y target est
--
Riken Vitamin Co., Ltd. engages in the food ingredient, food improving agents, health care, consumer and commercial foods, and chemical improving agents, and vitamins businesses in Japan. It offers dressing, such as non-oil dressings; seaweed; and extract / seasoning, soup, soup stock, retort-packed food, salad-related products, seafood / meat extracts, and cut wakame. The company also provides food improving agents, including food emulsifiers, processed oils, natural colorants, and vitamin E for emulsification, anti-staling, foaming, coagulation, anti-sticking, texture improvement, coloring, nutritional enhancement, and antioxidant to food manufacturers; and chemical improving agents for anti-fogging, plasticization, lubrication, anti-static, thickening, cleaning, mold release, dispersion, and antioxidant. In addition, it offers health care products, including crocetin, a natural yellow colorant; mekabu fucoidan, a viscous ingredient; carotenoids; vitamin; and improving agents, such as pork extract. The company was formerly known as Riken Vitamin Oil Co., Ltd. and changed its name to Riken Vitamin Co., Ltd. in 1980. Riken Vitamin Co., Ltd. was founded in 1917 and is headquartered in Tokyo, Japan.
www.rikenvitamin.jp1,857
Full-time employees
31 March
Fiscal year ends
Consumer Defensive
Sector
Packaged Foods
Industry
Related news
View more
Performance overview: 4526.T
Trailing total returns as of 21/01/2025, which may include dividends or other distributions. Benchmark is .
YTD return
1-year return
3-year return
5-year return
Compare to: 4526.T
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: 4526.T
View moreValuation measures
Market cap
70.62B
Enterprise value
62.49B
Trailing P/E
8.81
Forward P/E
--
PEG ratio (5-yr expected)
--
Price/sales (ttm)
0.78
Price/book (mrq)
0.90
Enterprise value/revenue
0.66
Enterprise value/EBITDA
4.28
Financial highlights
Profitability and income statement
Profit margin
9.75%
Return on assets (ttm)
5.12%
Return on equity (ttm)
11.84%
Revenue (ttm)
92.92B
Net income avi to common (ttm)
9.06B
Diluted EPS (ttm)
264.00
Balance sheet and cash flow
Total cash (mrq)
23.75B
Total debt/equity (mrq)
20.59%
Levered free cash flow (ttm)
--